Table 7.
The associations between the analyzed SNPs and endometrial cancer risk.
Genotype | Number of Cases | Endometrial Cancer | Control Group | OR | 95%CI | p-Value | |
---|---|---|---|---|---|---|---|
SLC11A2 | GG | 85 | 12 (60.0%) | 73 (71.6%) | 1 | - | |
TG | 33 | 7 (35.0%) | 26 (25.5%) | 1.638 | 1.235–1.702 | 0.348 | |
TT | 4 | 1 (5.0%) | 3 (2.9%) | 2.027 | 1.649–2.094 | 0.464 | |
GSTP1 | AA | 52 | 9 (45.0%) | 43 (47.8%) | 1 | - | - |
AG | 50 | 10 (50.0%) | 40 (44.4%) | 1.194 | 1.088–1.217 | 0.710 | |
GG | 8 | 1 (5.0%) | 7 (7.8%) | 0.683 | 0.598–0.702 | 0.654 |